clinical trial · NCT06742840
A Multiple Ascending Dose Trial of HRS-2129 in Healthy Subjects
Shandong Suncadia Medicine Co., Ltd.·phase1·completed·n = 23
PainHRS-2129HRS-2129 placebo
brief summary
The study is being conducted to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of HRS-2129 in healthy subjects.
started
Dec 30, 2024
primary completion
Jul 2, 2025
completion
Jul 2, 2025
last updated
Sep 3, 2025
official title
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-2129 Following Multiple Doses Administration in Healthy Subjects
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol